tradingkey.logo

tradingkey.logo
怜玢


QuidelOrtho Corp

QDEL
りォッチリストに远加
10.690USD
+0.350+3.38%
終倀 09-24 16:00ET
728.95M時䟡総額
損倱額盎近12ヶ月PER

QuidelOrtho Corpに぀いお 䌁業名

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corp プロフィヌル


䌁業コヌドQDEL
䌚瀟名QuidelOrtho Corp
䞊堎日Feb 01, 1991
最高経営責任者「CEO」Blaser (Brian J)
埓業員数6600
蚌刞皮類Ordinary Share
決算期末Feb 01
本瀟所圚地9975 Summers Ridge Road
郜垂SAN DIEGO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号92121
電話番号18585521100
りェブサむトhttps://www.quidelortho.com/
䌁業コヌドQDEL
䞊堎日Feb 01, 1991
最高経営責任者「CEO」Blaser (Brian J)

QuidelOrtho Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%

よくある質問

QuidelOrtho Corpの䞊䜍5名の株䞻は誰ですか


QuidelOrtho Corpの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Kenneth F. Buechler, Ph.D.

QuidelOrtho CorpQDELの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、QuidelOrtho Corpの株匏を保有しおいる機関は619瀟あり、保有株匏の総垂堎䟡倀は玄88.33Mで、党䜓の129.53%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-14180850.00増加しおいたす。

QuidelOrtho Corpの最倧の収益源は䜕ですか


2026Q1においお、Labs郚門がQuidelOrtho Corpにずっお最倧の収益を生み出しおおり、その金額は382.90Mで、党収益の60.69%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。